XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations and Comprehensive Loss (USD $)
3 Months Ended 150 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Consolidated Statements of Operations and Comprehensive Loss [Abstract]      
Research and development expenses, net $ 451,084 $ 504,245 $ 12,914,242
Selling, marketing and general and administrative expenses 436,102 183,579 4,491,884
Other income       (912)
Operating loss 887,186 687,824 17,405,214
Financing (income) expenses, net (150,267) [1] 655,771 [1] 8,418,384 [1]
Loss for the period 736,919 1,343,595 25,823,598
Other comprehensive (income) loss:      
Foreign currency translation adjustment 872 6,353 53,574
Comprehensive loss for the period $ 737,791 $ 1,349,948 $ 25,877,171
Loss per share (Basic and Diluted) $ 0.16 $ 0.25   
Weighted average number of shares outstanding (Basic and Diluted) (Note 3) 5,302,980 5,427,589   
[1] Includes ($145,870) relating to changes in the fair value estimate of the warrants with down-round protection and $611,060 of issuance costs allocated to the warrants with down-round protection, for the three month period ended March 31, 2014 and March 31, 2013, respectively.